Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Patient 12 had folfirinox and we have had 5 extraordinary results so far. Not sure if we can get more than the two in Complete Remission. The others I believe are stable disease.
With only 11 employees are cash burn is extremely low in employee salaries and benefits. In a perfect world the phase 2 would have already started but in the long run we are fine. We can partner on our pancreatic cancer with big pharma for a percentage of future sales or do a deal with the Baker Brothers like the deal they did with Kodiak. We have all sorts or options.
Mr tom, we are at $100 a share if patient #12 tumor blows up when they give an update on the pancreatic cancer trial. Remember we already dissolved 1.5 inches of the 2.25 inches of the tumor. We have 3 months of multiTaa treatment to this patient they haven't reported yet. If we get this second complete remission we are golden and all your charts won't matter with all due respect. Just saying
I believe BlackRock has been shorting our shares. After they drive our share price down, they place a larger buy. I will be very interested to verify this with their 13f that will be coming out shortly. Musk has called theM out as to shorting Tesla.
We have no side effects so why is the FDA being so nit picky? I understand they have to do a thourgh job but really. Their are many a drug with 30 side effects and get thru the approval process . Ours should be a slam dunk.
Whops why they can’t provide the details of their product?
Llttleguy Great work! Stick around. I wonder why the original manufacturers get provide the details?
MD Excellent post! We do have great results so far we just need to get AML approval to go to phase 2. Welcome to the board!
Atta. Yep that yawner of a report provided no real value as I see it. I agree with your assessment and am glad to hear from you. The key to this stock is our trial results. I will feel great if within the next 3 months patient 12 is in complete remission. Big pharma will do a partnership deal just based on our current Pancreatic Caner data. Obviously, w need the go added for AML. Looking at the big picture why wouldn't the FDA let us go to phase 2 with a none toxic working therapy when CART treatment is toxic and new study said it is bad for your heart?
Nothing enlightening in seeking alpha piece. A yawner imo. We just need to start phase 2 on AML, and get a second patient 12 in complete remission in pancreatic cancer trial. These items matter way more than some better communication. Lol
Merry Christmas!
If I was in charge of pancreatic cancer’s next trial. I would give MultiTAA after 1st month of of chemo and alternate the treatments and give more than 6 doses since our therapy is non toxic. I would increase the T cell counts to 40 million and add WTI to the mix. Not bad for a finance guy . Lol anybody have any better idea of mix?
Thanks Lloyd ! I see the presentation now! Looks good, we need patient 12 to hit complete remission. Stable disease is good too.
Lloyd when are where was this new info presented? Thanks I must have missed something.
007 I believe we are fine with you selling! Au revoir!
News alert Good data will be forthcoming on Marker! Lol what you guys want a news alert from PL? Lol
Their communication is fine. These people complaining are just impatient imo.
Thanks Epicare for the science explanation. I am only a finance person who works for one on the blue Cross plans. I know from a cost perspective we will love the outpatient cost side of this and no side effects. Been over 21 years with the blues so I know how we think
Eventually I will switch! It is a pain to go they that.
Fidelity is unbelievable! My margin buying power is now $34k and was $400 last week after they forced margin sales when Marker was $2.7 a share.
Happy Thanksgiving Maciste! Hang in there we will be fine. I listened to the pancreatic results on the Marker website the other day from July 20th presentation and the results on having a CR in 8 people is amazing. The only logical explanation on our current share price is short sale manipulation by large hedge funds to discourage retail investors to sell and they pick up our shares at these ridiculous prices.
These shorts are good at their game. It just gives people that believe in the science to double down. At he end of the day, this stock will soar once our Aml trial starts and we get the trial results.
Burr long and strong! 33.75% short interest rate today down 2% from yesterday. The rate has hovered at 38% for about a month.
Micro, FYI HARP (symbol) received $510 million from Abbie today for their 1/2 trial for the T cell immunotherapy product. I would expect Kim and Elms are working on a deal for pancreatic cancer.
Micro Your post is accurate . I believe they shorted to drive price down and are buy calls now too . I think the important point is institutions own 5,800,000 shares now if my math is good. Earlier this year phantom Lord calculatedly a total float of 11 million. So there is only 5.3 million shares for the rest of us. The fintel site must have correct the call volume by divining by 100 or 1,930 so that makes more sense
Florida. Fintel.io/sob/us/mrkr is the site
Rwest 191,000 calls purchased by citadel and Susquehanna too
Micro the 13f was just released and 15 new institutions bought get ahold or the info it is very clear all the institutions are gobbling up shares .
Fat 13f institutions own 5.8 million shares now! Which in my estimation leaves only 5.3 million shares available for the rest of us. The open question is how many of us are out there with large positions?
Buckboard do you personally know John Wilson I am curious?
Keith , I apologize for my comments . I thought you were purposely misleading about our pancreatic trial and now I believe you weren't. Since you ar my elder , I was taught to respect my elders so peace. I own Apple too, along with Microsoft, fisherv, Chase, PayPal and others. However, my largest holding is marker. I think in the las test 13f it is pretty clear to me that citadel and Susquehanna has led the hedge funds by shorting our shares and buying puts. If you look at their latest call position I believe they have now in the process of changing course since the own 190,000 calls which equates to 1,900,000 shares on the long side.
Ops i meant to say the 99,700 were puts volume as of 11-14
Citadel and Susquehanna drove our price down by shorting . They increased there short position at 11-14 to 99,700 from 73,400 previously . Now have calls from 17,700 now to 191,511 calls. So I believe we are going up now
Keith isn’t worth the time to respond too! I will try to be nice here. He doesn’t understand what trials are ongoing and what has stopped. Clearly , he has a nefarious agenda. Must be a short or he just hasn’t done his homework
Lending out shares to fidelity is fool’s gold! Here’s why. They offered this at $9 a share. Assume every share or 5,000,000 shares were lent out. The loss from $9 a share to $3 a share is $6 a share . $6 a share of market cap lost times 5,000,000 is $30,000,000 in lost market cap and their interest they have got isn’t not over $2.5 million. Fools gold lol
Atta:imo fidelity is unscrupulous that is why they are secretive! They are definitely trying to drive us down. Very sad but they have been exposed in my view. My estimate is that they have made about $5 million charging the shorters interest and have paid out $2.5 million to the lenders of shares . They have ruined their reputation imo for $2.5 million.
Fidelity is really unbelievable! 1st they tried to get me to loan out shares in one account. Now they have played games where I had buying power of say $20k earlier in week and now I get a margin call for $1k since I hadn’t moved money yet for my $2k that was on margin when I bought shares at $3.87 last week.
Well said lumpy!! I would add shares too but I up to my eyeballs in shares! At the end of the day Kite Cart kills people and our therapy there is no side effects. So after we answer the fda questions why wouldn’t they left us proceed to a pivotal phase 2 trial?
My take. We know the pep mix is non toxic so the FDA will approve once we provide them with answers. Remember Cart can be toxic with their billion genetically engineered crap with side effects including death so we will get over this hurdle . Our $70 million hedge funds guys will only double down in the future if we need more money.
Well, we didn’t get the best news today. However, big picture once we started on Aml phase 2 I will feel better. Big picture we have 8 years of Multi Taa studies and it is worth more than our measly market cap of $170. Big pharma doesn’t have 8 years to wait. We have a platform of multi Taa and they will at some point come a calling.
The state of Michigan just allowed all oncologists the ability to perform Cart for Aml even thou it cost up to $1 million and is toxic